Welcome to LookChem.com Sign In|Join Free


  • or


Post Buying Request

333963-40-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

333963-40-9 Usage


Lubiprostone is a bicyclic fatty acid with a unique mechanism of action that activates intestinal chloride ion channels, increasing intestinal water secretion and intestinal fluid chloride ion concentration. It is used for the treatment of chronic constipation and constipation associated with irritable bowel syndrome (IBS-C). Marketed as Amitiza by Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals America, Inc., it is recommended to be taken orally at a dosage of 24 μg twice a day with food. Precautions and side effects are similar to those for other prostaglandin-derived products.


Used in Pharmaceutical Industry:
Lubiprostone is used as a treatment for chronic idiopathic constipation in adults, addressing the need for novel agents to combat this condition that affects 4-5 million Americans and is often refractory to traditional therapy.
Lubiprostone is used as a treatment for constipation associated with irritable bowel syndrome (IBS-C), providing relief for patients suffering from this condition by increasing intestinal water secretion and chloride ion concentration, which helps to alleviate constipation symptoms.


Sucampo (US)


Synthesis of lupiprostone started with the tetrahydropyran (THP) protected (-)Corey lactone 30. Desilylation of 30 with TBAF in THF gave free carbinol in 82% yield which was oxidized with oxalyl chloride and DMSO to give corresponding crude aldehyde 31. Aldehyde 31 was condensed with dimethyl 3,3,-difluoro-2-oxoheptylphosphonate (32) in the presence of thallium ethoxide to give unsaturated difluoroketone 33 which was hydrogenated with H2 over Pd/C in ethyl acetate and the resulting ketone was subsequently reduced with sodium borohydride in methanol to give lactone 34 in excellent yield. The lactone 34 was reduced to lactol 35 with DIBAL at -78°C in toluene and the crude lactol 35 was condensed with 4-carboxybutyl triphenylphosphonium bromide (36) in the presence of t-BuOK in THF to yield compound 37. Crude 37 was reacted with benzyl bromide and DBU in dichloromethane (DCM) to give the benzyl ester in 96% yield. Oxidation of the alcohol with Collins reagent and removal of the THP protecting group under acidic conditions gave corresponding prostaglandin E2 benzyl ester 38. Finally, compound 38 was submitted to simultaneous benzyl ester group cleavage and double bond hydrogenation with H2 over Pd/C in ethyl acetate to give lubiprostone (V) in 94% yield.

Check Digit Verification of cas no

The CAS Registry Mumber 333963-40-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,3,9,6 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 333963-40:
149 % 10 = 9
So 333963-40-9 is a valid CAS Registry Number.



According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017


1.1 GHS Product identifier

Product name (2R,4aR,5R,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-heptanoic acid

1.2 Other means of identification

Product number -
Other names Prostan-1-oic acid,11,15-epoxy-16,16-difluoro-15-hydroxy-9-oxo-,(11alpha,15R)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:333963-40-9 SDS

333963-40-9Relevant articles and documents

Process for the preparation of Lubiprostone and intermediates thereof


Page/Page column 24, (2019/11/11)

The present invention relates to a novel process for preparing Lubiprostone and novel intermediates prepared from the process. The process of the present invention does not generate hydrogenated by-products that are difficult to be removed, and thus enables the production of Lubiprostone in an efficient and economical way.



Page/Page column 12-13, (2020/04/17)

A producing method of a 5-phenylpentyl hexahydrocyclopentafuran compound comprises: a step (a) of preparing a 5-phenylfe-1-tenyl hexahydrocyclopentafuran compound which is a compound of chemical formula 1; and a step (b) of producing a 5-phenylpentyl hexahydrocyclopentafuran compound which is a compound of chemical formula 2 by a hydrogenation transition reaction of the compound of chemical formula 1 in the presence of a hydrogenation catalyst, a hydrogen donor and a solvent. In chemical formula 1 and chemical formula 2, R1 is any one selected from a group consisting of hydrogen and hydroxy. The producing method by the present invention enables mass production.COPYRIGHT KIPO 2020

The preparation method of the ruby's forefront


, (2018/04/01)

The invention relates to a preparation method of lubiprostone, and concretely relates to a preparation method of highly pure lubiprostone represented by formula (I). The method comprises the steps of reducing an initial compound, oxidizing, and hydrolyzing in order to obtain a target compound. Compared with other methods, the method provided by the invention has the advantages of good process reappearance, simple operation, high yield, low cost, high purity of the above obtained product, suitableness for industrialized production, and very high economic benefit.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)


What can I do for you?
Get Best Price

Get Best Price for 333963-40-9